Nanocellulose-based Delivery Systems and Cervical Cancer: Review of the Literature

Author(s): Fatemeh Sadoughi, Jamal Hallajzadeh*, Zatollah Asemi*, Mohammad A. Mansournia, Bahman Yousefi

Journal Name: Current Pharmaceutical Design

Volume 27 , Issue 46 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

It has become clear that targeted therapy is one of the best options for decreasing the unpleasant side effects of existing common methods and reducing the number of deaths occurred due to many types of cancer. Biocompatible and non-toxic delivery systems are provided by nanomedicine for aiding targeted therapy in many diseases containing cancer. Cervical cancer (CC) is not only the most common gynecological cancer but also is ranked as the fourth common cancer between both men and women. Chemotherapy, radiotherapy, surgery, and immunotherapy are the approaches, which are being used for treating CC patients. However, more efficacy of these methods can be achieved with the help of nanomedicine and novel delivery systems. Nanocellulose is one of the agents used for designing these systems in order to deliver different drugs to a diversity of cancerous cells. In this review, we aim to investigate the competency of nanocellulose for establishing novel therapeutic methods for cervical cancer. We hope that our results help develop more drug delivery systems for targeted therapy to reduce the side effects and induce the efficacy of anti-cancer drugs.

Keywords: Nanomedicine, nanocellulose, drug delivery, carboxymethyl cellulose, gynecological cancer, targeted therapy, cervical cancer.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 27
ISSUE: 46
Year: 2021
Published on: 27 September, 2021
Page: [4707 - 4715]
Pages: 9
DOI: 10.2174/1381612827666210927110937
Price: $65

Article Metrics

PDF: 11